Skip to main content

Crohn’s Disease

Contribute to new therapies that are making breakthroughs in Crohn’s disease treatment.

Gut Problems Causing Discomfort

Crohn’s disease is a chronic inflammatory condition that affects the digestive tract, causing discomfort and symptoms such as abdominal pain, diarrhea, and rectal bleeding. Crohn’s disease presents a significant challenge in the medical field due to limited treatment options available on the market.

Hightower recognizes this gap and is actively working on developing novel drugs that offer both efficacy and safety for moderate to severe Crohn’s disease patients. Through rigorous research and clinical trials, Hightower Clinical aims to bring forth innovative therapies that can improve the management and outcomes of this complex condition.

Condition

Crohn’s Disease

Current Status

Upcoming

Location

Oklahoma

Study Information

Crohn's Disease

Study NameProtocol NumberSponsor
Crohn's Disease

MK7240

Merck

Frequently Asked Questions

What types of treatments are being investigated in these studies?

Hightower’s Crohn’s disease studies explore a variety of promising approaches, including new medications aimed at improving symptom control and quality of life.

How do I know if I qualify to participate in a study?

Each study has specific eligibility criteria. We encourage you to visit our website or contact us to learn more about individual studies and see if you might be a good fit.

What are the potential risks of participating in a clinical trial?

Some potential risks exist, such as side effects from new medications or additional doctor visits. Hightower investigators will provide a detailed explanation of all potential risks before your participation in any study.

Close Menu